265 related articles for article (PubMed ID: 21765411)
21. The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte α-granule biogenesis.
Lo RW; Li L; Pluthero FG; Leung R; Eto K; Kahr WHA
Blood; 2020 Aug; 136(6):715-725. PubMed ID: 32384141
[TBL] [Abstract][Full Text] [Related]
22. A dominant-negative GFI1B mutation in the gray platelet syndrome.
Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
[TBL] [Abstract][Full Text] [Related]
23. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
[TBL] [Abstract][Full Text] [Related]
24. The Nbeal2(-/-) mouse as a model for the gray platelet syndrome.
Deppermann C; Nurden P; Nurden AT; Nieswandt B; Stegner D
Rare Dis; 2013; 1():e26561. PubMed ID: 25003009
[TBL] [Abstract][Full Text] [Related]
25. Gray platelet syndrome: NBEAL2 mutations are associated with pathology beyond megakaryocyte and platelet function defects.
Pluthero FG; Kahr WHA
J Thromb Haemost; 2021 Feb; 19(2):318-322. PubMed ID: 33300270
[No Abstract] [Full Text] [Related]
26. Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome?
Nurden AT; Nurden P
Am J Hematol; 2016 Jul; 91(7):714-8. PubMed ID: 26971401
[TBL] [Abstract][Full Text] [Related]
27. Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome.
Collins JH; Mayer L; Guerrero Lopez JA
J Thromb Haemost; 2023 Jun; 21(6):1409-1419. PubMed ID: 37028650
[TBL] [Abstract][Full Text] [Related]
28. Platelet proteome and function in X-linked thrombocytopenia with thalassemia and
Bergemalm D; Ramström S; Kardeby C; Hultenby K; Eremo AG; Sihlbom C; Bergström J; Palmblad J; Åström M
Haematologica; 2021 Nov; 106(11):2947-2959. PubMed ID: 33054111
[TBL] [Abstract][Full Text] [Related]
29. Platelet α-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice.
Tariket S; Guerrero JA; Garraud O; Ghevaert C; Cognasse F
Transfusion; 2019 Jan; 59(1):32-38. PubMed ID: 30394544
[TBL] [Abstract][Full Text] [Related]
30. Newly recognized cellular abnormalities in the gray platelet syndrome.
Drouin A; Favier R; Massé JM; Debili N; Schmitt A; Elbim C; Guichard J; Adam M; Gougerot-Pocidalo MA; Cramer EM
Blood; 2001 Sep; 98(5):1382-91. PubMed ID: 11520786
[TBL] [Abstract][Full Text] [Related]
31. The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer.
Wijgaerts A; Wittevrongel C; Thys C; Devos T; Peerlinck K; Tijssen MR; Van Geet C; Freson K
Haematologica; 2017 Apr; 102(4):695-706. PubMed ID: 28082341
[TBL] [Abstract][Full Text] [Related]
32. Granule exocytosis is required for platelet spreading: differential sorting of α-granules expressing VAMP-7.
Peters CG; Michelson AD; Flaumenhaft R
Blood; 2012 Jul; 120(1):199-206. PubMed ID: 22589474
[TBL] [Abstract][Full Text] [Related]
33. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly.
Fabbro S; Kahr WH; Hinckley J; Wang K; Moseley J; Ryu GY; Nixon B; White JG; Bair T; Schutte B; Di Paola J
Blood; 2011 Mar; 117(12):3430-4. PubMed ID: 21263149
[TBL] [Abstract][Full Text] [Related]
34. Successful hematopoietic engraftment with gray platelets after allogeneic hematopoietic stem cell transplantation from gray platelet syndrome donor.
Katgi A; Ataca P; Kahraman S; Sevindik OG; Sonmez U; Solmaz SM; Piskin O; Demirkan F; Ozsan GH
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):208-10. PubMed ID: 23358204
[TBL] [Abstract][Full Text] [Related]
35. Defective Zn
Kiran Gotru S; van Geffen JP; Nagy M; Mammadova-Bach E; Eilenberger J; Volz J; Manukjan G; Schulze H; Wagner L; Eber S; Schambeck C; Deppermann C; Brouns S; Nurden P; Greinacher A; Sachs U; Nieswandt B; Hermanns HM; Heemskerk JWM; Braun A
Sci Rep; 2019 Jun; 9(1):8333. PubMed ID: 31171812
[TBL] [Abstract][Full Text] [Related]
36. Platelet dense granule secretion defects may obscure α-granule secretion mechanisms: evidence from Munc13-4-deficient platelets.
Harper MT; van den Bosch MT; Hers I; Poole AW
Blood; 2015 May; 125(19):3034-6. PubMed ID: 25953980
[No Abstract] [Full Text] [Related]
37. Nbeal2 interacts with Dock7, Sec16a, and Vac14.
Mayer L; Jasztal M; Pardo M; Aguera de Haro S; Collins J; Bariana TK; Smethurst PA; Grassi L; Petersen R; Nurden P; Favier R; Yu L; Meacham S; Astle WJ; Choudhary J; Yue WW; Ouwehand WH; Guerrero JA
Blood; 2018 Mar; 131(9):1000-1011. PubMed ID: 29187380
[TBL] [Abstract][Full Text] [Related]
38. The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.
Urban D; Li L; Christensen H; Pluthero FG; Chen SZ; Puhacz M; Garg PM; Lanka KK; Cummings JJ; Kramer H; Wasmuth JD; Parkinson J; Kahr WH
Blood; 2012 Dec; 120(25):5032-40. PubMed ID: 23002115
[TBL] [Abstract][Full Text] [Related]
39. Gray Platelet Syndrome-Unusual Presentation with Spontaneous Splenic Rupture: A Case Report and Literature Review.
Barghouthi DI; Abu-Hilal LH; Njoum Y; Hasan AD; Alshawwa K; Hourani F
J Investig Med High Impact Case Rep; 2023; 11():23247096231196697. PubMed ID: 37649376
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.
Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
Stem Cell Res; 2021 Aug; 55():102443. PubMed ID: 34237592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
